These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33287689)

  • 1. Associations of menopausal age with virological outcomes and engagement in care among women living with HIV in the UK.
    Okhai H; Tariq S; Burns F; Gilleece Y; Dhairyawan R; Hill T; Sabin CA
    HIV Res Clin Pract; 2020 Dec; 21(6):174-181. PubMed ID: 33287689
    [No Abstract]   [Full Text] [Related]  

  • 2. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study.
    Barber TJ; Geretti AM; Anderson J; Schwenk A; Phillips AN; Bansi L; Gilson R; Hill T; Walsh J; Fisher M; Johnson M; Post F; Easterbrook P; Gazzard B; Palfreeman A; Orkin C; Leen C; Gompels M; Dunn D; Delpech V; Pillay D; Sabin CA;
    Antivir Ther; 2011; 16(6):805-14. PubMed ID: 21900712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
    Geretti AM; Smith C; Haberl A; Garcia-Diaz A; Nebbia G; Johnson M; Phillips A; Staszewski S
    Antivir Ther; 2008; 13(7):927-36. PubMed ID: 19043927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.
    Smith CJ; Phillips AN; Hill T; Fisher M; Gazzard B; Porter K; Gilson R; Easterbrook P; Matthias R; Scullard G; Johnson MA; Sabin CA;
    J Infect Dis; 2005 Oct; 192(8):1387-97. PubMed ID: 16170756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
    Kahabuka MS; Woldeamanuel Y; Mbelele PM; Mpolya EA; Mpagama SG; Kessy JP; Manyazewal T
    BMC Infect Dis; 2024 Apr; 24(1):390. PubMed ID: 38605325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs.
    Adams JW; Marshall BDL; Mohd Salleh NA; Barrios R; Nolan S; Milloy MJ
    Drug Alcohol Depend; 2020 Jan; 206():107670. PubMed ID: 31711873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures.
    Benzie AA; Bansi LK; Sabin CA; Portsmouth S; Hill T; Johnson M; Gilson R; Easterbrook P; Gazzard B; Fisher M; Orkin C; Dunn D; Delpech V; Taylor GP; Walsh JC; Phillips AN;
    AIDS; 2007 Jul; 21(11):1423-30. PubMed ID: 17589188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy.
    Doyle T; Smith C; Vitiello P; Cambiano V; Johnson M; Owen A; Phillips AN; Geretti AM
    Clin Infect Dis; 2012 Mar; 54(5):724-32. PubMed ID: 22238167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
    Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
    Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study.
    Childs T; Shingadia D; Goodall R; Doerholt K; Lyall H; Duong T; Judd A; Gibb DM; Collins IJ;
    Lancet HIV; 2015 Apr; 2(4):e151-8. PubMed ID: 26413561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal HIV viral load testing during pregnancy and postpartum care in Gauteng Province, South Africa.
    Moyo F; Mazanderani AH; Kufa T; Sherman GG
    S Afr Med J; 2021 Apr; 111(5):469-473. PubMed ID: 34852890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with 10 years of continuous viral load suppression on HAART.
    Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
    BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.
    Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Holloway J; Johnson M; Phillips AN
    HIV Med; 2010 Mar; 11(3):216-24. PubMed ID: 20002781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral load in HIV-infected children on high activity antiretroviral therapy].
    Resino S; Bellón JM; León JA; Resino R; Muñoz-Fernández MA;
    Med Clin (Barc); 2007 Jan; 128(2):49-51. PubMed ID: 17266901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological rebound after suppression on highly active antiretroviral therapy.
    Mocroft A; Ruiz L; Reiss P; Ledergerber B; Katlama C; Lazzarin A; Goebel FD; Phillips AN; Clotet B; Lundgren JD;
    AIDS; 2003 Aug; 17(12):1741-51. PubMed ID: 12891060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.